Urbanization and daily exposure to biomass fuel smoke both contribute to chronic bronchitis risk in a population with low prevalence of daily tobacco smoking

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 2, 2016, Pages 186-195

  Miele, Catherine H ^a   Jaganath, Devan ^a,b   Miranda, J Jaime ^c,d   Bernabe Ortiz, Antonio ^c   Gilman, Robert H ^b   Johnson, Caroline M ^b   Diette, Gregory B ^a   Wise, Robert A ^a   Checkley, William ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

biomass fuel; chronic bronchitis; COPD; Peru; pollution; respiratory disease; tobacco; urbanization

Indexed keywords

FUEL; AIR POLLUTANT;

ABSENTEEISM; ADULT; AGE; AGED; ALTITUDE; ANTHROPOMETRY; ARTICLE; ASTHMA; BIOMASS; BLOOD SAMPLING; CHRONIC BRONCHITIS; CONTROLLED STUDY; DYSPNEA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; INDOOR AIR POLLUTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SOCIOECONOMICS; SPIROMETRY; URBANIZATION; ADVERSE EFFECTS; AIR POLLUTANT; BRONCHITIS, CHRONIC; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PERU; RURAL POPULATION; TRENDS;

ADULT; AIR POLLUTANTS; BIOMASS; BRONCHITIS, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PERU; PREVALENCE; RISK FACTORS; RURAL POPULATION; SMOKING; SPIROMETRY; URBANIZATION;

EID: 84946595375     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1067765     Document Type: Article

References (42)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
2. Burgel PR. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD Subjects. Chest 2009; 135: 975.
3. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965; 1: 775-779.
4. Guerra S, Sherrill DL, Venker C, et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009; 64: 894-900.
5. Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 228-237.
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 77-121.
7. Lee J, Cho MH, Hersh CP, et al. Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respir Res 2014; 15: 113.
8. Kim V, Davey A, Comellas AP, et al. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res 2014; 15: 52.
9. de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J 2012; 40: 28-36.
10. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130: 1129-1137.
11. Pelkonen MK, Notkola IL, Laatikainen TK, et al. Twenty-five year trends in prevalence of chronic bronchitis and the trends in relation to smoking. Respir Med 2014; 108: 1633-1640.
12. Accordini S, Corsico AG, Cerveri I, et al. Diverging trends of chronic bronchitis and smoking habits between 1998 and 2010. Respir Res 2013; 14: 16.
13. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
14. World Health Organization. WHO STEPwise Approach to Survalance (STEPS). Available from: http://www.who.int/chp/steps/manual/en/index.html. http://www.who.int/chp/steps/manual/en/index.html (. accessed 31 May 2014).
15. Lu M, Yao W, Zhong N, et al. Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology 2010; 15: 1072-1078.
16. World Health Organization. Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases. World Health Organization, Geneva, 2011.
17. Miranda JJ, Bernabe-Ortiz A, Smeeth L, et al. Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open 2012; 2: e000610-0.
18. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
19. Menezes AM, Perez-Padilla R, Jardim JB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
20. Howe LD, Galobardes B, Matijasevich A, et al. Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol 2012; 41: 871-886.
21. Jaganath D, Miranda JJ, Gilman RH, et al. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res 2015; 16: 40.
22. Miller MR. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
23. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1146-1161.
24. Pollard SL, Williams DAL, Breysse PN, et al. A cross-sectional study of determinants of indoorenvironmental exposures in households with and without chronic exposure to biomass fuel smoke. Environ Health 2014; 13: 1-12.
25. Quintana PJ, Samimi BS, Kleinman MT, et al. Evaluation of a real-time passive personal particle monitor in fixed site residential indoor and ambient measurements. J Expo Anal Environ Epidemiol 2000; 10: 437-45.
26. Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax 1994; 49: 1217-1221.
27. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study). Chest 2008; 133: 343.
28. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
29. Hankinson JL, Odencrantz, KR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 79-187.
30. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV 1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153: 1530-1535.
31. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
32. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
33. Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 2008; 12: 972-977.
34. Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax 2011; 66: 232-239.
35. Zhou Y, Zou Y, Li X, et al. Lung Function and Incidence of Chronic Obstructive Pulmonary Disease after Improved Cooking Fuels and Kitchen Ventilation: A 9-Year Prospective Cohort Study. PLoS Med 2014; 11: e1001621.
36. Baumann LM, Robinson CL, Combe JM, et al. Effects of distance from a heavily transited avenue on asthma and atopy in a periurban shantytown in Lima, Peru. J Allergy Clin Immunol 2011; 127: 875-882.
37. Lindgren A, Stroh E, Montnémery P, et al. Traffic-related air pollution associated with prevalence of asthma and COPD/chronic bronchitis. A cross-sectional study in Southern Sweden. Int J Health Geogr 2009; 8: 2.
38. Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2010; 42: 83-88.
39. Allender S, Foster C, Hutchinson L, et al. Quantification of urbanization in relation to chronic diseases in developing countries: A systematic review. J Urban Health 2008; 85: 938-951.
40. Izquierdo-Alonso JL, Rodriguez-GonzálezMoro JM, de Lucas-Ramos P, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med 2013; 107: 724-731.
41. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38.
42. Brusasco V. Spirometric definition of COPD: exercise in futility or factual debate? Thorax 2012; 67 (7): 569-570.